DSpace at RU >

Browsing by Author Wit, J.M.

Full Text	Issue Date	Title	Author(s)
	2011	Genome-wide screening in human growth plates during puberty in one patient suggests a role for RUNX2 in epiphyseal maturation.	Emons, J.; Dutilh, B.E.; Decker, E.; Pirzer, H.; Sticht, C., et al
	2011	Ethical issues at the interface of clinical care and research practice in pediatric oncology: a narrative review of parents' and physicians' experiences.	Vries, M.C. de; Houtlosser, M.; Wit, J.M.; Engberts, D.P.; Bresters, D., et al
	2011	Case report: low circulating IGF-I levels due to Acid-Labile Subunit deficiency in adulthood are not associated with early development of atherosclerosis and impaired heart function	Rensing, K.L.; Duyvenvoorde, H.A. van; Cramer, M.J.; Teske, A.J.; Prokop, M., et al
	2011	The severe short stature in two siblings with a heterozygous IGF1 mutation is not caused by a dominant negative effect of the putative truncated protein	Duyvenvoorde, H.A. van; Doorn, J. van; Koenig, J.; Gauguin, L.; Oostdijk, W., et al
	2011	The effect of oxandrolone on voice frequency in growth hormone-treated girls with Turner syndrome	Menke, L.A.; Sas, T.C.J.; Koningsbrugge, S.H. van; Ridder, M.A. de; Zandwijken, G.R., et al
	2011	Effect of oxandrolone on glucose metabolism in growth hormone-treated girls with Turner syndrome	Menke, L.A.; Sas, T.C.J.; Stijnen, T.; Zandwijken, G.R.; Muinck Keizer-Schrama, S.M.P.F. de, et al
	2010	Adult height in children with growth hormone deficiency: a randomized, controlled, growth hormone dose-response trial.	Sas, T.C.J.; Ridder, M.A. de; Wit, J.M.; Rotteveel, J.J.; Oostdijk, W., et al
	2010	Short stature associated with a novel heterozygous mutation in the insulin-like growth factor 1 gene.	Duyvenvoorde, H.A. van; Setten, P.A. van; Walenkamp, M.J.; Doorn, J. van; Koenig, J., et al
	2010	Efficacy and safety of oxandrolone in growth hormone-treated girls with turner syndrome.	Menke, L.A.; Sas, T.C.J.; Muinck Keizer-Schrama, S.M.P.F. de; Zandwijken, G.R.; Ridder, M.A. de, et al
	2010	Pediatric oncologists' attitudes towards involving adolescents in decision-making concerning research participation.	Vries, M.C. de; Wit, J.M.; Engberts, D.P.; Kaspers, G.J.L.; Leeuwen, E. van
	2010	The effect of the weak androgen oxandrolone on psychological and behavioral characteristics in growth hormone-treated girls with Turner syndrome.	Menke, L.A.; Sas, T.C.J.; Visser, M. de; Kreukels, B.P.; Stijnen, T., et al
	2010	The effect of oxandrolone on body proportions and body composition in growth hormone-treated girls with Turner syndrome.	Menke, L.A.; Sas, T.C.J.; Zandwijken, G.R.; Ridder, M.A. de; Stijnen, T., et al
	2009	Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.	Lind van Wijngaarden, R.F. de; Siemensma, E.P.; Festen, D.A.; Otten, B.J.; Mil, E.G. van, et al
	2009	Human acid-labile subunit deficiency: clinical, endocrine and metabolic consequences.	Domene, H.M.; Hwa, V.; Argente, J.; Wit, J.M.; Camacho-Hubner, C., et al
	2009	Attitudes of physicians and parents towards discussing infertility risks and semen cryopreservation with male adolescents diagnosed with cancer.	Vries, M.C. de; Bresters, D.; Engberts, D.P.; Wit, J.M.; Leeuwen, E. van
	2009	Intelligence of very preterm or very low birthweight infants in young adulthood.	Weisglas-Kuperus, N.; Hille, E.T.; Duivenvoorden, H.J.; Finken, M.J.; Wit, J.M., et al
	2008	Clinical and molecular characteristics of 1qter microdeletion syndrome: delineating a critical region for corpus callosum agenesis/hypogenesis.	Bon, B.W.M. van; Koolen, D.A.; Borgatti, R.; Magee, A.; Garcia-Minaur, S., et al
	2008	Mental and motor development before and during growth hormone treatment in infants and toddlers with Prader-Willi syndrome.	Festen, D.A.; Wevers, M.; Lindgren, A.C.; Bohm, B.; Otten, B.J., et al
	2008	Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit.	Duyvenvoorde, H.A. van; Kempers, M.J.E.; Twickler, T.B.; Doorn, J. van; Gerver, W.J., et al
	2008	Screening rules for growth to detect celiac disease: a case-control simulation study.	Dommelen, P van; Grote, F.K.; Oostdijk, W.; Keizer-Schrama, S.M.; Boersma, B., et al
	2008	Randomized controlled GH trial: effects on anthropometry, body composition and body proportions in a large group of children with Prader-Willi syndrome.	Festen, D.A.; Wijngaarden, R. de Lind van; Eekelen, Marielle van; Otten, B.J.; Wit, J.M., et al
	2007	Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment.	Festen, D.A.; Visser, T.J.; Otten, B.J.; Wit, J.M.; Duivenvoorden, H.J., et al
	2007	Psychomotor development in infants with Prader-Willi syndrome and associations with sleep-related breathing disorders.	Festen, D.A.; Wevers, M.; Weerd, A.W. de; Bossche, R.A. van den; Duivenvoorden, H.J., et al
	2007	Functional outcomes and participation in young adulthood for very preterm and very low birth weight infants: the Dutch Project on Preterm and Small for Gestational Age Infants at 19 years of age.	Hille, E.T.; Weisglas-Kuperus, N.; Goudoever, J.B. van; Jacobusse, G.W.; Ens-Dokkum, M.H., et al
	2005	Cutoff levels of 17-alpha-hydroxyprogesterone in neonatal screening for congenital adrenal hyperplasia should be based on gestational age rather than on birth weight.	Kamp, H.J. van de; Oudshoorn, C.G.; Elvers, B.H.; Baarle, M. van; Otten, B.J., et al
	2004	Genotype-phenotype correlation in patients suspected of having sotos syndrome.	Boer, L.M.; Kant, S.; Karperien, M.; Beers, L. van; Tjon, J., et al
	2002	Final height gain by GH therapy in children with idiopathic short stature is dose dependent.	Wit, J.M.; Rekers-Mombarg, L.T.M.
	1997	Effect of growth hormone treatment on craniofacial growth in Turner's syndrome	Rongen, C.; Born, E. van de; Prahl-Andersen, B.; Teunenbroek, A. van; Manesse, P., et al
	1997	Growth before and during growth hormone treatment in children operated for craniopharyngioma	Hogeveen, M.; Noordam, C.; Otten, B.J.; Wit, J.M.; Massa, G.G.
	1996	Catch-up growth after prolonged hypothyroidism	Boersma, B.; Otten, B.J.; Stoelinga, G.B.A.; Wit, J.M.
	1996	Yearly stepwise increments of the growth syndrome dose results in a better growth response after four years in girls with Turner Syndrome	Teunenbroek, A. van; Muinck Keizer-Schrama, S.M.P.F. de; Stijnen, T.; Jansen, M.; Otten, B.J., et al
	1996	PT-1: Clinical aspects	Pfaffle, R.W.; Kim, C.; Otten, B.J.; Wit, J.M.; Eiholzer, U., et al
	1995	Growth hormone treatment in two dose regiments in girls with Turner syndrome: final height results	Massa, G.G.; Otten, B.J.; Muinck Keizer-Schrama, S.M.P.F. de; Delamarre-van Waal, H.A.; Jansen, M., et al
	1995	Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone respons to secretagogues	Wit, J.M.; Boersma, B.; Muinck Keizer-Schrama, S.M.P.F. de; Nienhuis, H.E.; Oostdijk, W., et al